Tyson Foods, COMSCORE, Aratana Therapeutics Stocks Moving Today

TSN, SCOR, and PETX are among the stocks on the move today

Feb 6, 2017 at 2:01 PM
facebook X logo linkedin


U.S. stocks are treading water this afternoon. Among specific equities in focus today are chicken producer Tyson Foods, Inc. (NYSE:TSN), data specialist COMSCORE, Inc. (NASDAQ:SCOR), and veterinary drug stock Aratana Therapeutics Inc (NASDAQ:PETX). Here's a quick look at what's moving shares of TSN, SCOR, and PETX.

SEC Subpoena Overshadows Tyson Foods Earnings Beat

TSN was last seen 3.5% lower at $63.11, as news of a subpoena from the Securities and Exchange Commission (SEC) takes precedent over the company's earnings beat. The company believes the subpoena is connected to price-fixing allegations. Looking back, the shares have now shed 18.1% since their all-time high of $77.05 from early September, and bullish analysts may be wondering if it's time to rethink their positions. At the moment, five of seven brokerage firms rate Tyson Foods, Inc. a "strong buy," with zero "sell" ratings to be found. 

COMSCORE Tanks Amid Delisting Chatter

SCOR is the biggest loser on the Nasdaq today, down 26% at $24 -- and earning a sport on the short-sale restricted list -- after the company said it will not be able to meet a Feb. 23 deadline for restating past financial results, and could be delisted (subscription required) from the exchange as a result. The shares were already well below their February annual peak of $43.53 coming into today, and are now on pace for their lowest close since late June. Short sellers, meanwhile, are probably racking up gains with their bearish positions on COMSCORE, Inc. Short interest has increased 84% since mid-August, putting over 15% of the stock's float in the hands of short sellers. 

FDA Request Bites Aratana Therapeutics

PETX is also hurting today, down 18.4% at $6.56, after the Food and Drug Administration (FDA) requested additional information on the company's new manufacturing partner for Entyce, an appetite stimulant for dogs. The request will delay the launch of Entyce to late 2017. Aratana Therapeutics Inc is set to close below its 50-week moving average for the first time since July, which should be good news for the few options traders that have targeted the stock. Specifically, put open interest on PETX currently sits at a 52-week high, albeit on light absolute levels.

Get a jump-start on the day's stock market news with Schaeffer's free Opening View newsletter.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI